D86 Sarcoidosis

Name of the Condition

• Common Name(s): Sarcoidosis
• Medical Term: Sarcoidosis

Summary

Sarcoidosis is a systemic inflammatory disease characterized by the formation of granulomas (clusters of inflammatory cells) in various organs, most commonly the lungs and lymph nodes. The condition can affect multiple body systems, including the skin, eyes, liver, and heart, and may present with a wide range of symptoms or be asymptomatic.

Causes

The exact cause of sarcoidosis is unknown, but it is believed to result from an abnormal immune response to an environmental trigger, such as an infection, allergen, or toxin, in genetically susceptible individuals. The immune system overreacts, leading to chronic inflammation and granuloma formation.

Risk Factors

• Age: Most commonly diagnosed in individuals between 20 and 40 years old.
• Ethnicity: Higher prevalence in African-American and Northern European populations.
• Family History: A family history of sarcoidosis may increase risk.
• Gender: Slightly more common in females.

Symptoms

• Persistent dry cough and shortness of breath (if lungs are involved).
• Fatigue and general malaise.
• Skin lesions, such as erythema nodosum or lupus pernio.
• Eye inflammation (uveitis) causing blurred vision or pain.
• Swollen lymph nodes, particularly in the chest or neck.
• Joint pain or swelling.
• Fever and weight loss.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging, and laboratory tests. A chest X-ray or CT scan may reveal granulomas or enlarged lymph nodes. Blood tests can show elevated inflammatory markers or abnormal calcium levels. A definitive diagnosis often requires a biopsy of affected tissue (e.g., lung, skin, or lymph node) to identify granulomas and rule out other conditions.

Treatment Options

Treatment depends on the severity and organ involvement. Mild cases may not require therapy and are monitored. For symptomatic or progressive disease, corticosteroids (e.g., prednisone) are commonly used to reduce inflammation. Other immunosuppressants (e.g., methotrexate) may be prescribed for refractory cases. Topical treatments or eye drops may address localized symptoms.

Prognosis and Follow-Up

The prognosis varies; many patients experience spontaneous remission, while others have chronic or relapsing disease. Regular follow-up is essential to monitor organ function, especially the lungs and eyes. Long-term management may be needed for persistent symptoms or complications.

Complications

• Pulmonary fibrosis (scarring of lung tissue) leading to respiratory failure.
• Chronic eye disease, potentially causing vision loss.
• Cardiac involvement, including arrhythmias or heart failure.
• Neurological symptoms, such as facial nerve palsy.
• Kidney stones or renal dysfunction due to elevated calcium levels.

Lifestyle & Prevention

• Avoid smoking to reduce lung irritation.
• Protect eyes from UV exposure to prevent inflammation.
• Maintain a balanced diet and stay hydrated.
• Manage stress, as it may exacerbate symptoms.
• Follow up with healthcare providers to monitor disease activity.

When to Seek Professional Help

Seek medical attention if you experience persistent respiratory symptoms, unexplained weight loss, severe fatigue, vision changes, or new skin lesions. Prompt evaluation is critical for early diagnosis and treatment.

Tips for Medical Coders

When coding for sarcoidosis (ICD-10 D86), ensure documentation specifies the affected organ system (e.g., pulmonary, cutaneous) or notes if it is unspecified. Include details on disease activity (active, inactive, or chronic) and any complications to support accurate code assignment. Verify that the code aligns with the clinical documentation and does not conflict with other conditions.